These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16078777)

  • 41. Selective serotonin reuptake inhibitor-induced mydriasis.
    Larson M; Folstein S
    J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):138-9. PubMed ID: 10673818
    [No Abstract]   [Full Text] [Related]  

  • 42. [Increased perioperative blood loss during treatment with paroxetine].
    Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypersensitivity to paroxetine.
    Mera MT; Pérez BV; Fernández RO; Iglesias JF
    Allergol Immunopathol (Madr); 2006; 34(3):125-6. PubMed ID: 16858890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors.
    Naranjo CA; Sproule BA; Knoke DM
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S35-47. PubMed ID: 10471171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focus on paroxetine.
    Green B
    Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective serotonin reuptake inhibitors: adverse effects, toxicity and interactions.
    Mitchell PB
    Adverse Drug React Toxicol Rev; 1994; 13(3):121-44. PubMed ID: 7827222
    [No Abstract]   [Full Text] [Related]  

  • 48. Rare case of serotonin syndrome with therapeutic doses of paroxetine.
    Paruchuri P; Godkar D; Anandacoomarswamy D; Sheth K; Niranjan S
    Am J Ther; 2006; 13(6):550-2. PubMed ID: 17122538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors].
    Apelland T; Gedde-Dahl T; Dietrichson T
    Tidsskr Nor Laegeforen; 1999 Feb; 119(5):647-50. PubMed ID: 10095385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paroxetine-induced excessive yawning.
    Harada K
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):260. PubMed ID: 16594955
    [No Abstract]   [Full Text] [Related]  

  • 51. Paroxetine discontinuation syndrome in association with sertindole therapy.
    Walker-Kinnear M; McNaughton S
    Br J Psychiatry; 1997 Apr; 170():389. PubMed ID: 9246265
    [No Abstract]   [Full Text] [Related]  

  • 52. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paroxetine-induced somnambulism.
    Kawashima T; Yamada S
    J Clin Psychiatry; 2003 Apr; 64(4):483. PubMed ID: 12716257
    [No Abstract]   [Full Text] [Related]  

  • 54. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective serotonin reuptake inhibitors for depression?
    Drug Ther Bull; 1993 Jul; 31(15):57-8. PubMed ID: 8375273
    [No Abstract]   [Full Text] [Related]  

  • 56. Paroxetine in the treatment of adolescent major depression.
    Correll CU; Pleak RR
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1269; author reply 1270. PubMed ID: 12410065
    [No Abstract]   [Full Text] [Related]  

  • 57. Paroxetine-induced dysarthria in a 42-year-old man with pathologic laughing.
    Park JK; Kang WS; Cho AR
    Aust N Z J Psychiatry; 2011 Dec; 45(12):1096-7. PubMed ID: 21970420
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical effects of serotonin reuptake inhibitors--a review].
    Feighner JP
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():9-15. PubMed ID: 7959528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paroxetine in the treatment of adolescent major depression.
    Silveira R; Jainer AK; Singh R
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1270; author reply 1271. PubMed ID: 12410066
    [No Abstract]   [Full Text] [Related]  

  • 60. Transient ischemic attack reported with paroxetine use.
    Manos GH; Wechsler SM
    Ann Pharmacother; 2004 Apr; 38(4):617-20. PubMed ID: 14966255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.